Subsequently, sMICA and sMICB inhibit the function of NKG2D and damage the cytotoxic effect of NK cells, causing tumor cells to be unable to be effectively killed by NK cells and CD8+ T cells, mediating tumor immune escape and disease progression. Here, CD8A is linked to neoplasm.